A case of cutis laxa acquisita was studied with the aim of defining th
e molecular defects involved and comparing them with those of an inher
ited form of cutis laxa. In the acquisita form of cutis laxa ultrastru
ctural and biochemical observations confirmed a dramatic reduction of
dermal elastin, whereas collagen content was normal. Elastin mRNA expr
ession as well as tropoelastin production by dermal fibroblasts, in vi
tro, were normal compared with control cells, as revealed by in situ h
ybridization and enzyme-linked immunosorbent assay, respectively. Lysy
l oxidase activity, measured on cultured fibroblasts, was reduced to 6
0% compared with age-matched control subjects. Unlike control skin fib
roblasts or fibroblasts from inherited cutis laxa, the affected skin c
ells from cutis laxa acquisita predominantly expressed an elastolytic
activity identified as cathepsin G. Patient serum also has reduced ela
stase inhibitory capacity and reduced levels of alpha 1-antiproteinase
inhibitor (alpha 1-antitrypsin). Although cutis laxa acquisita is a h
eterogeneous group of disorders, findings in this patient were consist
ent with excessive loss of cutaneous elastin due to the combined effec
ts of several factors, such as low lysyl oxidase activity together wit
h high levels of cathepsin G and reduction of circulating proteinase i
nhibitor(s).